AMOXIL-K 1000

The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.

In case of any discrepancies, please contact us at tel. +380 44 490 75 22

Film-coated tablets.

The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.

In case of any discrepancies, please contact us at tel. +380 44 490 75 22

  • Treatment of bacterial infections in adults and children caused by microorganisms sensitive to the preparation "Amoxil-K 1000": acute bacterial sinusitis; acute otitis media; confirmed exacerbation of chronic bronchitis; community acquired pneumonia; cystitis; pyelonephritis; infections of the skin and soft tissues, including cellulite, animal bites, severe dentoalveolar abscesses with a common cellulitis; Infection of bones and joints, incl. osteomyelitis.
  • 1 tablet contains 875 mg of amoxicillin (in the form of amoxicillin trihydrate), 125 mg of clavulanic acid (in the form of potassium clavulanate); Excipients: microcrystalline cellulose, sodium starch glycolate (type A), silicon dioxide, colloidal anhydrous, magnesium stearate, coating mixture (contains: hydroxypropyl methylcellulose, titanium dioxide (E 171), copovidone, polydextrose, polyethylene glycol (macrogol), medium chain triglycerides).

Buy from partners

Check at pharmacy

Order

Check at pharmacy

Order

Order

or order from partners

Legal Agreement for Information Access

This section contains information intended for healthcare institutions and professionals (hereinafter "licensed medical specialists") and includes specialized professional information about pharmaceuticals, including prescription medications. This information encompasses details such as drug names, descriptions, usage instructions, potential side effects, contraindications, and other professional information. The information is for informational purposes only and should not be used as a guide for self-diagnosis or treatment. Medication should be used only as directed by a physician, as self-treatment can be harmful to health.

Do you confirm that you have reviewed this restriction on information access and are a healthcare specialist?

No

Дякуємо за звернення!

Ваша форма успішно відправлена. Якщо у вас виникли додаткові питання, будь ласка, заповніть форму на сайті або зателефонуйте нам

Pharmacovigilance

If you have any information about an adverse reaction and/or lack of efficacy of an Arterium Corporation drug, please fill out the form: